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2. Norwegian abstract - Norsk sammendrag 
Bakgrunn 
Behovet for å kvalitetssikre kirurgisk behandling av rygglidelser og utvikle kliniske 
retningslinjer er veldokumentert. Derfor ble Nasjonalt kvalitetsregister for ryggkirurgi 
opprettet. Metodene som brukes må være valide og reliable. Hensikten med avhandlingen 
var å evaluere målemetodene og å vise hvordan registerdata kan brukes til kvalitetssikring 
og forskning, slik at pasientbehandlingen kan bli tryggere og mer effektiv. 
Metode 
1325 pasienter ble operert og fulgt i ett til to år (n= 633). Omfattende informasjon om 
pasientene, diagnose og behandling ble samlet inn sammen med pasient rapporterte 
resultatmål (PROM), det vil si endring av smerte, fysisk funksjonsnivå, livskvalitet og 
yrkesdeltakelse. I hvor stor grad utvalgte PROM var valide og reliable, beheftet med 
systematiske målefeil og om de kunne brukes til å skille de med gode og dårlige 
operasjonsresultat, ble vurdert. Spesielt ble det fokusert på de som ble verre etter kirurgi og 
hvilke kliniske retningslinjer som bør gjelde for å forhindre forverring. 
Resultat 
Instrumentet EuroQol 5D ga valide og reliable evalueringer av helserelatert livskvalitet og 
bør kunne benyttes til kostnad/nytte analyser, men var mindre sensitivt og spesifikt i 
evalueringer av undergrupper av pasientene sammenliknet med sykdomsspesifikke mål som 
Oswestry Disability Index og numerisk skala for bensmerte. Bedring av PROM var ikke 
forskjellig hos de som ikke svarte på rutinemessig postoperativ kontroll sammenliknet med 
de som svarte. Fire prosent av pasientene som ble operert med mikrokirurgisk fjerning av 
skiveprolaps opplevde at de ble verre etter kirurgi, God fysisk funksjon og langvarig 
sykemelding før operasjon økte risikoen for å bli verre. 
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Konklusjon 
Registeret som samler data fra den daglige driften i de kliniske avdelingene kan gi valid og 
reliabel informasjon som kan benyttes både til kvalitetssikring og forskning. Dette kan gi ny 
kunnskap, for eksempel om risikofaktorer, noe som kan bidra til å gjøre behandlingen 
tryggere og mer effektiv. 
 
Cand.med. Tore K. Solberg 
Nevrokirurgisk avdeling, UNN/ IKM, UiT 
Hovedveileder: Professor Tor Ingebrigtsen, UNN/IKM, UiT 
Biveileder: Professor Øystein Petter Nygaard, St. Olavs Hospital, NTNU 
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5.1 What is the thesis about? 
This thesis is a result of more than ten years work with a clinical registry for surgical 
treatment of degenerative disorders in the lumbar spine.  The articles mark different key 
steps in the process of establishing the Norwegian registry for spine surgery (NORspine). The 
aim is to give the reader an introduction to some basic scientific concepts and methods in 
the process of collecting registry data, reporting results and developing clinical guidelines. 
Thus, the articles illustrate some crucial steps in the “clinical audit circle”; which is aimed at 
reviewing clinical practice so that it can be improved if advocated (Figure 1) [1, 2]. Hopefully, 
this evidence based framework for continuous clinical audit will contribute to a safer and 
more effective health service for the patients. The registry data can also give clinicians 
opportunity to do clinical research, as close to their patients and “real life” as possible. This 
lies at the heart of evidence based medicine.  
Figure 1: The clinical audit cycle 
The clinical audit cycle
Determine scope
Set Standards
Report & compare results
Review
Make Change Collect data
Paper 1 and 3
Paper 2
Paper 3 and 4
 
The figure is modified after Redfern and Norman, King's College, London 1996. 
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5.2  What is a clinical registry? 
The Scandinavian countries, especially Sweden and Denmark, have been at the forefront of 
developing clinical registries. According to the definition of the Danish ministry of health: 
“A clinical registry contains selected, quantifiable variables which can assess parts of or the 
full quality of a certain treatment, by documenting treatment results for a limited group of 
patients based on individual lines of treatment” (my translation)  [3]. Norway has been 
lagging behind Denmark and Sweden in this field. An exception is the orthopedic registries, 
and especially the Norwegian arthroplasty register, which started post marketing 
surveillance of total hip replacements in 1987 [4], and has earned high national and 
international recognition. The most developed and successful registry for spine surgery in 
the world is probably the Swedish spine register (Swespine), which has existed for more than 












6. Background/rationale for clinical registries 
6.1 Evidence based medicine 
According to Sacett et. al, “evidence based medicine is the conscientious, explicit, and 
judicious use of current best evidence in making decisions about the care of individual 
patients. The practice of evidence based medicine means integrating individual clinical 
expertise with the best available external clinical evidence from systematic research” [7]. 
The argument that “everyone already do” falls before striking evidence of variations in use 
of health services, treatment strategies and follow-up [8-13].  
Evidence can be obtained from the basic sciences of medicine, and especially clinical 
research, and not only from randomised controlled trials (RCTs) [14-18]. Previously accepted 
knowledge can be invalidated and treatments can become more targeted, powerful and safe 
[19-22]. Without using current best evidence, clinical practice risks to be rapidly outdated 
and its quality will lapse. 
6.2 Quality 
Quality in health care as been defined by the American Institute of Medicine as: "The degree 
to which health services for individuals and populations increase the likelihood of desired 
health outcomes and are consistent with current professional knowledge." [23] This 
statement links quality to evidence based medicine and the clinical perspective, namely that 
indicators of quality should be linked to patients outcomes [24-26]. 
6.3 Quality indicators and patient reported outcome measures (PROMs) 
Lack of reliable and relevant information has been a major obstacle for improvement of 
health care across the world [27, 28].Traditionally, monetary issues like hospital activity and 
budget spending have been used for setting goals and priorities in the health services. 
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Administrative databases were developed to facilitate and monitor the structure (e.g. 
numbers of hospital staff and beds) and process of delivering the health care (e.g. patients’ 
access to the services and numbers of procedures performed).  Quality indicators were 
defined on the basis of such readily accessible information, for two main reasons: (1) 
Structure and process are easy to monitor (2) and to modify [25]. However, most of this 
information represent indirect measures (proxies) for quality and are mainly cross sectional 
[25, 29, 30]. In the clinical community quality has traditionally been linked to what comes 
out of the health service, rather than what is put into it. During the last decades also policy 
makers and administrators have realized that quality assessment requires use of outcome 
measures [19], with main focus on treatment effectiveness and safety for the patients [23, 
27, 28, 31-33]. Accordingly, new supporting electronic information systems to collect a 
broader spectrum of data that were relevant, timely, and informative to the clinical teams, 
were requested [19, 28, 31, 34-39].  
This paved the way for clinical registries and the use of patient reported outcome measures 
(PROMs). PROMs are multidimensional and provide insight into how the impact of diseases 
and treatments are perceived by the patients, e.g. in terms of pain, disability and health-
related quality of life (HRQoL) [33]. Combining information about the structure and process 
of health care delivery with PROM data can bring about new and relevant knowledge both 
for patients and health care providers. This approach to quality might help to give answers 
to some crucial questions, of concern to any doctor involved in clinical practice: 
 Is what we think happens to our patients true? 
 What works, and what does not work? 
 Is our treatment effective according to current standards?  
 Which risk factors for unfavourable outcomes should we be aware of?  
 Is the treatment safe? 
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6.4 Safety and unfavourable outcomes 
Safety concerns are not new. The origin of the phrase “Primum non nocere”, "first, do no 
harm" is believed to be from the Hippocratic Oath which was written late 5th century BC 
[40]. It is still one of the principal precepts of medical ethics around the world. However, 
even today monitoring and detection of error and harm seems to have been neglected in 
healthcare organisations [28].  
An adverse event is unintended harm to the patient caused by an act of commission or 
omission, rather than underlying disease [41]. Adverse events during hospital admission 
affect nearly one out of ten patients, 40-50 % are related to surgical procedures and 5-7 % 
are lethal [42-45]. It is important to differentiate between a medical error and an adverse 
event. Not all adverse events (e.g. surgical complications) are preventable or the result of 
medical errors, which are failures in the process of care [41] [30]. Of all the adverse events, 
more than half are preventable [42, 45-48].  Their consequences are probably so costly that 
strong efforts to improve the quality probably would be cost effective [49]. Despite 
increased focus on patient safety the last decade, the harm resulting from medical care 
remains high [28, 36, 37, 50, 51]. According to the National Health Plan for Norway, 
“Systems shall be established to learn from mistakes, so that they are not repeated, and 
these systems shall support the development of the health service as a learning 
organization. It is important for the service’s legitimacy that there is openness about errors 
and improving quality” [31]. 
A clinical registry can provide timely and relevant data on safety issues, i.e. integrated 
information about risk factors (e.g. co-morbidity), process data (e.g. use of antibiotic 
prophylaxis), adverse events (e.g. complications) and the actual outcome (e.g. disability) 
[27,36, 52]. A short term follow up can identify immediate effects related to the treatment 
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whereas a long term follow-up can evaluate if they persist. Prospectively collected PROMs 
can assess treatment effectiveness [26, 34, 38, 50]. Lack of effectiveness is also a safety 
issue. Because risk is inherent in any procedure, reducing the number of unnecessary and 
inefficient operations is important.  From a population perspective, this may have a greater 
impact on complication rates than improving the technical quality of surgery [15].  
 
6.5 Validity and reliability of outcome measures 
Validity is concerned with the crucial relationship between concept and indicator; i.e. does 
the instrument “hit the right target”, does it measure what it purports to measure? (Figure 
2). Reliability quantifies how stable and consistently a measurement is in “keeping the 
target”, i.e. does measurement of the same phenomenon gives the same result, when 
repeated either in sequence (test-retest or inter-observer reliability) or by different 
observers (inter-observer reliability)? (Figure 2). Random error is inherent in any 





Valid but unreliableUnvalid & unreliable
Unvalid but reliable Valid & reliable
 
6.6 Bias, confounding and causation  
Non-random, or systematic measurement error, can lead to biased conclusions about 
causality between an exposition and an observed effect, and can invalidate the results, even 
though correct statistical methods are used [53]. 
There are two main types of systematic measurement error; information and selection bias. 
To avoid information bias, instruments used for measurements have to be valid (Paper I and 
III). Loss to follow-up is an important potential source for selection bias if patients who fail to 
respond have different outcomes from those who do not (Paper II).   
An association or correlation between two variables is necessary for causation, but does not 
automatically imply that one causes the other. Criteria such as the strength, coherence and 
consistency of an association, plausibility, temporal sequence and evidence of a dose-
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response effect, lend support to a causal relationship [54].  Lack of causation may be due to 
confounding; i.e. there may be known or unknown factors, other than the exposition, that 
are responsible for the effect. This may lead to biased conclusions. This bias can however be 
corrected for, provided that confounding was anticipated and the requisite information 
gathered from the start of a study [55]. The effect of confounding can be evaluated in 
multivariate analyses (Paper II and IV).  
 
6.7 Chance and significance testing  
Information, selection and confounding bias can cause highly statistically significant but  
incorrect results. If none of these factors seems to be present, chance may be another 
source for false results. 
 A p-value is not an arbiter of validity or casual relationship, it only evaluates whether a 
difference is found by chance or not. The frequently used  p-value threshold of 0.05  has no 
basis in medicine, but stems from experiments in agriculture and industry, and does not give 
strong evidence against the null hypothesis in clinical research [55, 56].The p-value indicates 
the likelihood of a false-positive result; a difference was found in the study, although it does 
not exist in a broader population (type I error). A smaller p-value (e.g. < 0.001) decreases the 
likelihood of a type I error [57]. A false-negative result (type II error) is often due to lack of 
statistical power to discover an association that could exist in a broader population. The 
large numbers of patients handled in clinical registries will give high statistical power and the 
risk for committing both type I and II errors in analyses will be reduced. However, even small 
and irrelevant effect sizes will reach statistical significance, and use of p-values will often be 
meaningless. It is therefore important to define clinically meaningful effect sizes, before the 
hypotheses testing starts (paper III).  In contrast to p- values, confidence intervals (CIs) show 
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the strength, direction, and plausible range of a difference as well as the likelihood of chance 
occurrence. Presenting CIs is therefore more informative, especially when focus is placed on 
the clinical importance of the range of values in the interval [57]. 
 
6.8 The role of registry data in clinical research 
The explanatory randomized controlled trial (RCTs) is regarded as the gold standard in 
clinical research for evaluating efficacy of a new treatment [20, 58]; i.e. does it work under 
ideal circumstances? This question should be answered before any new treatment is 
implemented. The goal of the thorough recruitment and randomization process of an RCT is 
to eliminate threats to its internal validity, namely confounding and selection bias. Even 
though the internal validity of a well conducted and unbiased RCT is high, concerns about 
the external validity often remains: Does the new treatment work when it is used in a wide 
range of practices for a broader mix of patients? [59]. An increasing interest for more 
pragmatic trials and has therefore emerged [60-62]. The goal of registry studies is to not to 
evaluate efficacy, but effectiveness: To understand how treatments work in daily clinical 
practice, when physicians and patients add their own preferences and perceptions to the 
decision-making process [63]. Therefore, selection bias is inevitable. As a consequence, using 
observational cohort studies to compare effectiveness of different treatments by adjusting 
for baseline covariates (to compensate for lack of randomization) is controversial and often 
not advisable [22, 64-66], but may be the only option e.g. for studying the effects of adverse 
events such as complications [67]. However, if similar conditions are treated consistently 
different but at two centres, the relative effectiveness of the methods can be studied in 
matched populations. Registry data can also aid in generating hypothesis and sample size 
calculations for RCTs. Moreover, in some instances RCTs are impracticable or unlikely to be 
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performed, i.e. in evaluation of treatments for rare conditions and complex interventions 
[68-70]. Non patentable medical technology or drugs are rarely evaluated in explanatory 
RCTs [15, 66]. In these cases clinicians will have to rely on the best evidence available from 
other sources. Efficiency describes whether an intervention is worth its costs to patients or 
society, in cost-effectiveness or cost-utility analyses [71] by use of generic HRQoL 
instruments like the EuroQol 5D (EQ-5D). Also in this domain registries can play an important 
role. Apart from translational research (phase V studies), registries can ensure post-
marketing surveillance of new surgical devices and techniques being introduced (phase IV 
studies). In contrast to registry studies, the RCT design is often not applicable to evaluate risk 
factors. For instance, it is unethical to randomize patients to risk behaviour such as smoking 
or alcohol abuse.  
The main advantage with clinical registry cohorts is that they can utilize the confounders 
eliminated in an RCT (e.g. co-morbidity and life style issues.) for risk factor analyses. [72] 
[73]. These risk factors are often frequent in the “true” population of daily clinical practice, 
where registry data are collected. Clinical guidelines based on carefully conducted analyses 
on prognostic factors from well maintained registry cohorts will have the highest possible 
scientific evidence level [74-76] (Table 1, upper right corner). Identifying modifiable risk 
factors for adverse outcomes is obviously important, but detecting subgroups of patient who 
benefit most from certain procedures is also valuable [15].  
In summary, well designed and well-conducted registry studies can provide essential 
information with high level of evidence about risk factors, safety and outcomes, when new 




Table 1: Levels of evidence by type of study  
Expert opinion without explicit critical 
appraisal, or based on physiology, bench 
research or "first principles"
Expert opinion without explicit critical 
appraisal, or based on physiology, bench 
research 
5
Case-series (and poor quality prognostic 
cohort studies)




Systematic reviews  (with homogeneity) of 
case-control studies
3a
"Outcomes" Research "Outcomes" Research2c
Retrospective cohort study or follow-up of 
untreated control patients in an RCT
Individual cohort study (including low 
quality RCT; e.g., <80% follow-up)
2b
Systematic review  (with homogeneity) of 
either retrospective cohort studies or 
untreated control groups in RCTs
Systematic review  (with homogeneity) of 
cohort studies
2a
All or none case-seriesAll or none 1c
Individual inception cohort study with >
80% follow-up; Clinical Decision Rule 
validated in a single population
Individual RCT (with narrow Confidence 
Interval)
1b
Systematic review  (with homogeneity) of 
inception cohort studies; Clinical Decision 
Rule validated in different populations





The table is modified after: Phillips B et al., Oxford centre for evidence-based medicine (May 
2001). Available from: http://www.cebm.net/index.aspx?o=1025 
 
 
6.9 Why a registry for spine surgery? 
Patients with degenerative disorders in the lumbar spine often have chronic low back pain 
and/or radiating leg pain, with or without neurological deficits. The consequences are 
disability, reduced HRQoL as well as reduced working capability. In western societies, 
lumbar-spine disorders account for higher costs resulting from disability and absenteeism 
from work than any other somatic disease category [78, 79]. Lumbar disc herniation is one of 
the most common indications for surgery performed in US hospitals [80, 81]. In Norway, 
5832 operations for degenerative disorders in the lumbar spine were performed in 2011 
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[82]. The clinical syndromes are associated with radiological signs of “spondylosis” with disc 
and facet joint degeneration, bony spurs, thickening of ligaments and inflammation. These 
degenerative changes can cause disc herniation, spinal stenosis, instability and deformity. 
Patients with lumbar spondylosis report surprisingly low HRQoL, in fact worse than patients 
with osteoarthritis of hip and knee, rheumatoid arthritis, peripheral vascular disease, 
prostate cancer, diabetes mellitus, chronic obstructive lung disease, heart failure and renal 
failure [83] [84]. In most cases the indication for surgery is relative to the subjective 
complaints of the patients. A decision has to be based on a trade-off between possible 
benefits and risks of the treatment.  
Decompression of impinged neural structures to relieve radiating pain is the most common 
indication for surgery. The operative technique used for similar conditions can vary between 
institutions and surgeons, depending on their education, experience, equipment and 
preferences [85]. Different surgical procedures are used, ranging from microsurgery to more 
extensive “open techniques” such as laminectomies, sometimes combined with fusion 
surgery for instability.  The results are variable, and the key to a successful outcome is to use 
the right indication for surgery for the right patients. If carefully selected, these patients can 
experience an improvement at the level of those operated with hip and knee replacement 
[83] [86], which are regarded to be some of the most successful operations in terms of 
improvement in HRQoL and cost-effectiveness [87, 88]. 
For those operated for chronic low back pain without instability or spinal stenosis, the 
results are more disappointing [87]. Comprehensive surgery is often used, e.g. instrumented 
fusion or disc prosthesis. Still, there is little evidence in the literature to support one 
treatment strategy instead of the other [89-92], or either of them instead of 
multidisciplinary rehabilitation programmes [93-95].  Moreover, the correlation between 
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radiological findings and the clinical diagnosis is low [96-98], and overuse especially of MRI 
leads to problems with interpretability and increasing costs [99]. The development of new 
treatments are mainly industry driven, and new surgical instrumentation methods are often 
introduced without sufficient evidence for efficacy or effectiveness [100, 101]. Some of 
these procedures can put the patients at higher risks for complications, morbidity and even 
death [102].  
Few areas of clinical medicine are as controversial as the surgical treatment of some of the 
conditions related to spondylosis, as evidenced by large variations in surgical rates between 
and presumable similar populations [13, 101, 103, 104]. 
Carefully planned RCTs in this field have been troubled with issues of blinding (for patients 
and physicians and investigators), willingness to consent to randomization and post-
randomization treatment crossover, limiting their practicality and validity [63, 105]. As a 
consequence, treatment recommendations are often made with much ambiguity [101, 106], 
and will have to rely upon other types of studies.  
Several authors have argued that clinical registries can contribute to clinical guideline 
development, which is strongly warranted in this field [15, 16, 18, 81, 107]. 
 
6.10 A short history of the NORspine 
In 2000 we established a local clinical registry for quality control and research for all patients 
operated for degenerative disorders in the lumbar spine at the Department of Neurosurgery 
at the UNN. The questionnaires used up to 2004 (paper I, II and IV) are shown in Appendix A. 
To reduce the work load for the doctors, collection and registration and follow-up involved 
the whole staff at the department as part of their daily routines. An independent observer at 
follow-up (research nurse) was used. This ensured good data quality. A large cohort of 
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patients recruited from daily clinical practice was created with follow-up at 3, 12 and 24 
months after surgery. Follow-up visits at the outpatient clinic were replaced by 
administration of postal questionnaires at 24 months from 2005 and at 12 months from 
2006. 
The concept of our registry and the first results were presented at a meeting in The 
Norwegian Society for Spine Surgeons in 2001, which asked us to initiate a Norwegian 
national registry, based on the methods we had developed at UNN. A formal mandate 
provided by the Norwegian directory of health to the HN RHF, initiated my work at SKDE in 
2005. Despite very strict Norwegian legislation and lack of IT-infrastructure, solutions were 
fond for routing encrypted sensitive information form all surgical units through the national 
“safe highway” on the internet (The Norwegian health network) to a common server placed 
behind the electronic “firewall” of UNN. Simultaneously the first secure, central platform 
and database for this purpose in Norway (www.helseregister.no) had been developed by 
HN-IKT. In 2006 the Norwegian data protection authorities approved the protocol and data 
management so that the local registry could be expanded to the NORspine. A steering group, 
consisting of both orthopaedic and neurosurgeons, representing all five (later four) regional 
health authorities in Norway, was established. This group was supported by the three 
relevant surgical societies, namely the Norwegian Society of orthopaedic surgeons, 
Norwegian society of neurosurgeons and Norwegian society of spine surgeons [82]. Online 
registration of data was available from October 2006 (appendix B). The registry database 
was linked to the National Population Registry of Norway by the national 11-digit personal 
identification number. In this way, we obtained continuously updated information about 
changes of home address and dates of death in the study population. In 2009 results from 
the registry were made available to the surgical units in the first interactive online reports. In 
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September 2009, version 2.0 of the NORspine was launched. The most important changes 
were that all follow-ups (at 3 and 12 months) from then were managed by the central 
registry unit, distributing questionnaires directly to and from patients, without involving the 
hospitals (Figure 3). Further details concerning the design of the registry, registration 
procedures and reporting are available in Norwegian at http://www.unn.no/nasjonalt-
kvalitetsregister-for-ryggkirurgi/category5972.html (“Registerbeskrivelse”, Praktisk 
veileder”, “Brukermanual”). The national coverage rate has increased steadily over the year, 
and currently 80.5 % of all the surgical units report to the NORspine. In 2010 we developed 
an algorithm for merging data form the NORspine and the National Patient Registry of 
Norway [82].At the individual level the coverage increases every year, and in 2012 
approximately 60% of the patients for the target conditions operated in Norway were 
included in the registry (unpublished data). In comparison: The coverage of the Swespine 
was 75% [6]. 
 




7. Aims, rationale and methods 
The aim of the thesis was to provide a scientific basis for some key methods used in the 
NORspine; for assessing, reporting and comparing outcomes after surgery for degenerative 
disorders of the lumbar spine. Thus, the articles illustrate some crucial steps in the “clinical 
audit circle” [2] (Figure 1); namely to gather valid and reliable data,  set valid standards and 
benchmark criteria for comparing and reviewing results, so that guidelines can be developed 
and clinical practice can be changed . 
 
7.1 Rationale, study population and main methods of each paper  
7.1.1 Paper I:  
Health-related quality of life assessment by the EuroQol-5D can provide cost-utility data in 
the field of low-back surgery. 
Rationale 
Generic and preference-weighted measures of health-related quality, like the EQ-5D, can 
provide clinical data for cost-utility analyses across different diseases and treatments. 
Disease specific HRQoL instruments are of no value for such purposes. On the other hand, 
generic questionnaires are regarded to be less responsive than disease-specific instruments 
and might be to general to assess specific conditions. The EQ-5D was not validated for use in 
the field of low back surgery when the local registry at UNN was established. To avoid 
information bias, it was crucial to validate the questionnaire, especially before expanding 
into a national registry. 
Study population 
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A cohort of 326 patients were operated for degenerative disorders in the lumbar spine at 
the Neurosurgical Department, UNN  between 1st of January 2000 and 1st of June 2003 and 
were followed for one year. 
Main methods  
The EQ-5D was validated against the disease specific ODI and other outcome measures. 
Patients who were admitted for elective surgery or who were evaluated at follow-up during 
October and November 2001 completed an extra set of the EQ-5D questionnaire for test–
retest reliability assessments. 
7.1.2 Paper II:  
Would loss to follow-up bias the outcome evaluation of patients operated for degenerative 
disorders of the lumbar spine? 
Rationale 
In limited clinical trials one can make vigorous attempts to trace and retain cohort members. 
Such efforts are too expensive and resource-demanding to be feasible in large clinical 
registries like the NORspine, which tries to recruit all patients operated in Norway. 
Researchers who use registry data will therefore have to deal with higher numbers of non-
respondents at follow-up. Different outcomes of non-respondents will lead to selection bias, 
and biased research conclusions. 
Study population  
A cohort of 633 patients operated with low back surgery from 1st of January 2000 through 
31st December 2003 at UNN.  
Main methods 
Patients not responding at two years of follow-up were traced for a standardized telephone 
interview, performed by one dedicated doctor. 
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7.1.3 Paper III:   
Can we define success criteria for lumbar disc surgery? Estimates for a substantial amount of 
improvement in core outcome measures. 
Rationale 
In order to monitor surgical outcomes and compare results from different institutions, it is 
mandatory to develop validated benchmark for “success” criteria based on core outcome 
measures of the NORspine.  
Study population 
Multicenter cohort of the first 692 consecutive patients were operated for lumbar disc 
herniation at 16 different surgical units and reported to the NORspine between October 
2006 and March 2008, and followed for one year. 
Main methods 
The global perceived scale of change was used as an external criterion, and success was 
defined as those who reported that they were “completely recovered” or “much better”. 
(Table 2) 
 
7.1.4 Paper IV:  
The risk of "getting worse" after lumbar microdiscectomy. 
Rationale 
A frequent concern among the patients is the risk of “getting worse” after the operation. 
Risk factors for deterioration of functional status and HRQoL after lumbar microdiscectomy 
had not been reported previously. 
Study population 
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A cohort of 180 consecutive patients were operated with microdiscectomy for lumbar disc 
herniation at UNN from 1st of January 2000 to 1st of June 2003 and followed for one year. 
Main methods  
Deterioration was defined as an increase in ODI score (more disability) at follow up. Risk 
factors for deterioration were assessed in multivariate analyses. 
 
7.2 Research questions of the thesis 
7.2.1 Avoiding information and selection bias (Paper I, II and III) 
 
1. Is EQ-5D a valid, reliable and responsive instrument for measuring HRQoL 
compared to a widely used and validated disease specific instrument, the ODI? 
2. Can EQ-5D be used to define a successful outcome after surgery?  
3. How many patients do not respond at long term follow up? 
4. Will loss to follow-up bias outcome assessments?  
5. What are the risk factors for not responding? 
 
7.2.2 Creating benchmark criteria for standardized reporting (Paper III and IV) 
 
1. Can we define success criteria for lumbar disc surgery? 
2. Which of the core instruments are most valuable to use for defining success? 
3. What is a reasonable definition of failed surgery? 
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7.2.3 Using registry data for risk assessment and clinical guideline development (Paper 
IV) 
 
1. What is the risk of “getting worse” after lumbar microdiscectomy? 
2. Which risk factors are important? 
 
7.3 General features concerning patients and methods 
7.3.1 Patients 
The patient population described in paper in paper II was consecutively included at the at 
the neurosurgical department at UNN. This cohort was established as a research population 
preceding the national registry. The populations of paper I and IV were sub-cohorts of the 
larger cohort of paper II.  
Paper III evaluated a multicenter cohort from the NORspine, comprising the first patients 
included during implementation period of the registry. 
7.3.2 Inclusion criteria 
All consecutive patients operated for degenerative disorders in the lumbar spine. 
Definition of degenerative disorders: 
Disc herniation, degenerative disc disease, spinal stenosis, isthmic or degenerative 
spondylolisthesis / degenerative scoliosis, synovial cysts, spondylarthrosis /spondylosis. 
“segmental instability” or other non neoplastic disorders which can cause pain, with or 
without signs of instability   
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7.3.3 Exclusion criteria  
• Patients unable to give informed consent due to cognitive deficits or reduced 
consciousness 
• Children < 16 years 
• Patients with serious drug abuse or severe psychiatric disorders 
• Patients with fractures, primary infections or malignant conditions in the spine 
• Patients unable to respond to the declaration of consent and/or the questionnaires due to 
language barriers. 
 
7.3.4 Data collection, general features 
All questionnaires used for outcome assessments were self-administered and identical at 
admission for surgery (baseline) and follow-up. The baseline questionnaire included 
additional questions about demographics and lifestyle issues. 
During the hospital stay, the surgeon recorded data concerning diagnosis, treatment, co 
morbidity, employment status, duration of symptoms and complications according to a 
standard registration form. 
Finally, all forms were collected and checked for completeness and registered to the 
database by a dedicated research nurse. 
 
7.3.5 Follow-up 
At 3 and 12 months  
A dedicated, trained hospital nurse collected the questionnaires at follow up and 
interviewed the patients about employment status and complications using a standard 
registration form at an outpatient clinic. 
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Paper III (exception): At 12 months after surgery, a questionnaire was distributed by regular 
post, completed at home by the patients, and returned in the same way.  
 
At 24 months (only Paper II): 
 Patients operated in 2000 and 2001 were summoned for visits at the outpatient clinic. 
Patients operated in 2002 and 2003 received questionnaires by ordinary postal mail. Non-
respondents were traced and interviewed by telephone. 
 
7.3.6 Questionnaires (Appendix A-B) 
For each case, approximately 350 different variables were recorded at baseline and follow-
up in local registry at UNN and later in the NORspine database. They can be divided in three 
main categories: 
Patient specific data at baseline: Demographics (age, sex, body mass index, socioeconomic 
data (e.g. marital status, educational level, employment status), other known risk factors 
which might affect the outcome after surgery (e.g. duration of symptoms, previous 
operations, co morbidity, smoking habits) 
Process data: E.g. diagnosis (clinical and radiological), treatment (type of operation), 
duration of surgery and of hospital stay, use of prophylactic antibiotic treatment, completed 
by doctor or nurse.  
Patient reported outcome measures (PROM) [26]: 
A set of validated instruments which are recommended in the literature were used [108]: 
Oswestry Disability index (ODI):  
Physical function in daily living and disease specific HRQoL (range 0 -100, 0= no disability) 
[109-112]. 
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EuroQol 5D (EQ-5D):  
Generic measure of HRQoL (range -0.540 – 1, 1= best HRQoL). Suitable for estimating quality 
adjusted life years (QALY) in economic evaluations [113-115]. 
Leg and back pain 
Likert scale for pain in back/leg last week (Range 1-7, no – worst conceivable pain), until 
January 2004 
Visual analogue scales (VAS, range 0-100, 0= no pain) [116,117]until October 2006 
Numeric rating scales (NRS, range 1-10, 0= no pain) [118,119], from October 2006 
General health:  
VAS, range 0-100, (100=  perfect health) [115].  
Employment status [120,121].  
Global effects 
Perceived benefit of operation: Global perceived change scale (Table 2) [122]: 
Five point scale until October 2006  
Seven point scale from October 2006 (Table 2) 
Complications, reported by doctor or nurse [123,125].  
 
7.4 Ethical considerations 
Informed consent was obtained from all participants. The registry protocol was approved by 
the Norwegian data protection authorities. The protocol of the first study from 2005 (Paper 
IV) was formally presented to our regional ethical committee for medical research, which 
concluded that the study was a quality control project, and consequently not in need of their 
approval. They had no objections to the data collection, since this had been approved by the 
Norwegian data protection authorities. The rest of the study protocols were therefore only 
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discussed with the ethical committee. The conclusion, at that time, was that also these 
studies could be classified as clinical audit studies. 
In accordance with Norwegian rules and legislations, there has been a tradition for involving 
the regional ethical committee in studies concerned with new treatments or merging of data 
from different sources, but not in studies aimed at quality control of standard clinical 
practice.  However, more recently there has been an increasing awareness that the 
distinction between research and quality control is unclear. It is obvious that analyses of 
data from clinical registries require the use of research methods and that new knowledge is 
provided. Most of the study protocols involved in clinical audit will therefore have to be 
presented to regional ethical committees for medical research in the future [126].  
 
7.5 Statistical analyses 
Baseline characteristics and differences in outcome between groups were assessed with 
one-way analyses of variance (ANOVA) or analysis of covariance with adjustment for 
baseline scores (ANCOVA, general linear model), independent-samples t-test, Mann-Whit-
ney U-test, or Chi-square test. Within-group change scores changes were evaluated with 
paired t-test or Wilcoxon’s matched-pairs signed rank test depending on the distribution of 
the data. Central tendency was presented as mean when normally distributed, and as 
median when skewed. Normal distribution was assessed by the Kolmogorov-Smirnov test. 
Confidence intervals (CIs) for medians were calculated according to McKean and Schrader 
[127]. Effect size (ES) was estimated according to the method of Kazis et al. [128]. We 
assessed risk factors first in univariate, and then multivariate analyses using linear and 
logistic regression models. To determine the optimal cut-offs for the benchmark criteria on 
the outcome scores, we used receiver operating characteristic (ROC) curve analyses, looking 
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at the sensitivity and specificity for various cut-off values and the percentage of 
misclassification. The area under the curve (AUC), was calculated to evaluate how accurate 
the instruments could differentiate according to the benchmark criteria. Test–retest 
reliability was assessed by the intraclass correlation coefficient (ICC) [129], and internal 
consistency of the EQ-5D was measured by calculating Cronbachs’ alpha [130]. SPSS for 

















8. Main Results 
8.1 Avoiding information and selection bias (Paper I, II and III) 
The EQ-5D showed good reliability, with respect to test-retest accuracy (ICC = 0.82 at 
baseline and 0.87 at follow-up) and internal consistency (Chronbachs alpha= 0.69 at baseline 
and 0.76 at follow-up) .The validity of the EQ-5D and ODI in the assessments of pain, 
functional status, health state and employment status were equal. The overall ES was 
somewhat larger for the ODI (EQ-5D=1.3 and ODI=1.5), but the ranges of the ES between 
those who reported from “no” to “very much” benefit of the operation were almost equal 
(EQ-5D=2.1 and ODI=2.0).  
The ROC curve showed that the ODI performed better in identifying clinically important 
improvements (Paper I and Paper III). Among patients operated for lumbar disc herniation 
(paper III) the sensitivity/specificity values for the ODI and leg pain were acceptable, 
whereas they were low for the EQ-5D. The EQ-5D performed better in identifying patients 
with unfavourable outcomes (Paper I), as indicated by the larger negative ES of the EQ-5D in 
the group of patients who had no benefits of the operation as compared to the ODI.  
In paper II we did not find different outcomes among non-respondents as compared to the 
respondents. However non-respondents were younger and had fewer complications. 
Forgetfulness seemed to be the main reason for not responding. 
 
8.2 Creating benchmark criteria for standardized reporting (Paper III and IV) 
The definition of successful outcome is illustrated in table 2. The cutoff values for success for 
the mean change scores were 20 (ODI), 2.5 (NRS back), 3.5 (NRS leg). According to the cutoff 
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estimates, the proportions of successful outcomes were 66% for the ODI and 67% for the 
NRS leg pain scale 
Of the patients 4% had got worse one year after lumbar microdiscectomy, as measured by 
an increase in ODI score. When adding them with patients who, had an unfavourable ODI 
raw score (> 39) at follow-up and those who were reoperated, the failure rate increased to 9 
and then to 12%. 
 
8.3 Using registry data for risk assessment and clinical guideline 
development  (Paper IV) 
Of the patients 4% got worse. Only (43%) out of the patients who had a deterioration in ODI 
score also had a “poor” ODI raw score (> 39) at follow-up. Independent risk factors of 
deterioration were long duration of sick leave and relatively small health problems (disability 










The principle finding of this thesis is that a clinical registry for spine surgery, integrated in the 
daily workflow of a busy surgical department, can provide valid and reliable data for quality 
control and research.  
 
9.1 Avoiding information and selection bias 
Patient populations 
The patients included in paper I and IV were sub-cohorts of the population in paper II. Only 
1.5% of the patients operated were not included in the registry (Figure 4). The surprisingly 
high inclusion rate was reached because quality control had been given the highest priority 
at the Neurosurgical Department at UNN, and the whole staff by was involved. Especially the 
strong dedication of the research nurses was important. It is not difficult to argue, that the 
populations in paper I, II and IV are representative, ensuring no selection bias. Biased 
reporting at follow-up is also less likely, since the consultations were performed by 
presumably independent observers (trained nurses), and not the surgeons themselves. The 














 In paper III, which is based on national registry data, we did not know the exact inclusion 
rate at each hospital and the loss to follow-up rate was 23%. In case of selective inclusion at 
some hospitals, our results on the amount of patients considered to have a successful 
outcome may be inaccurate. However, the aim of the study was to define cut-offs for 
success over a range of outcomes, rather than assessing the effectiveness of the treatment. 
Furthermore, paper II indicates that we could treat the non-respondents as if they were 
missing at random in the analyses. It is therefore unlikely that selective reporting at follow-
up would influence the cut-off estimates for success. The improvement we found of the ODI, 
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and back and leg pain after surgery for disc herniation were also similar to those reported 
from the Swedish spine registry [6] 
A major asset was that we finally were able to obtain responses from 97% of the patient 
population. Since the non-respondents did not return the postal questionnaires (paper II), 
there was no other option than to use telephone interview. However, this may have 
replaced a potential selection bias with an information bias, if patients would respond 
differently to interviews. Moreover, the patients were interviewed with a twelve months 
mean delay with respect to the two years follow up. Even though outcomes seem to be 
stable over many years [6, 131, 132], we can not exclude that a memory problems (recall 
bias) might be present. Non-respondents were younger and had experienced fewer 
complications than the respondents. The CI for the association between having experienced 
a complication and responding was wide, but the association at the lower level of the 
interval was very strong, while the p-value only showed borderline significance (p= 0.07). 
This indicates that a type II error might be present. Consequently these findings should be 
reassessed in a larger population. Importantly, we found no evidence indicating that not 
responding was due to more adverse outcomes or other health problems. 
Being summoned for follow-up visits at the outpatient clinic obviously created a 
commitment among the patients, since the likelihood for responding increased (paper III).  
Due to high cost and administrative burden, registry participants will still have to be 
contacted at home. Forgetfulness especially among the younger people appeared to be an 
important cause, but may be an excuse for indifference. In our modern society, people are 
repeatedly contacted through postal mail and social media by commercial companies and 
other organizations. Many of them are conducting surveys. This may cause a kind of fatigue 
and/or indifference which we were unable to classify correctly. Since there was no 
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previously validated questionnaire for classifying reasons for not responding available, we 
had to rely on the “expert opinion” of our study group. It can not be ruled out that these 
factors might represent a source for information bias.  
9.2 Outcome measures and benchmarking 
We found that the reliability of the EQ-5D was acceptable. Acceptable accuracy has also 
been reported for the other PROMs we have used; e.g. in a study from the Swespine (for leg 
and back pain) and a Norwegian survey (for the ODI) [133, 134].  
In large clinical registries like the NORspine, it is important that generic questionnaires are 
short enough to secure a high inclusion rate. The EQ-5D is brief, efficient to administer and 
highly acceptable to respondents and investigators. It can be used across conditions and 
treatments and for assessing cost per quality adjusted life years (QALYs). In paper I, we 
concluded that this instrument could be suitable for such purposes.  However, recent studies 
indicate EQ-5D may be too short, and a new 5-level version of the EQ-5D has now been 
developed to improve the instrument's sensitivity and to reduce ceiling effects [135, 136]. A 
weakness of the methods used in paper I was that we did not assess the measurement error 
extensively enough by calculating the minimal detectable change (MDC). Based entirely on 
the distribution of the data, the MDC quantifies the smallest amount of change that is 
possible to detect beyond the underlying measurement error. For an instrument like EQ-5D, 
MDC should ideally be greater than the minimum clinically important difference (MCID) 
[137, 138], which also was omitted from the analyses. In retrospect, the statement “It was 
also impossible to calculate minimally clinical important difference MCID from our data set”, 
is probably incorrect. Moreover, we could have evaluated the sensitivity and specificity 
values of the EQ-5D for detecting a clinical meaningful improvement, which we found to be 
insufficient in paper III. Consequently, the EQ-5D should not be used for estimation of MCID 
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or for sample size calculations. According to the developers of the EQ-5D, it should be 
supplemented by a disease-specific questionnaire especially in studies focusing on disease 
specific problems, and not only overall treatment effects [139].  
A problem with the ODI is lack of a clear distinction between pain and disability. The mix of 
different constructs makes it difficult to know what it measures, and reflects shortcomings in 
its theoretical foundation, i.e. content and construct validity.  Moreover, even the disease 
specific ODI, covering ten different items (activities of daily living), could fail to address 
issues that are important to patients. Individuals might also weight the importance of each 
item differently according to preferences. How the effect of an operation is perceived will 
also depend on the expectations the patient had in advance [140, 141], but both 
expectations and preferences are too complex concepts to be monitored in a clinical 
registry. We therefore used a global effect scale (Likert scale) for outcome evaluations and 
for defining success criteria [122]; “How much benefit have you had from the operation?” An 
answer will most probably reflect both preferences and expectations, but in retrospect. One 
study showed that global change scale ratings are strongly influenced by the current health 
status of the patient and that accuracy may decrease as transition time increases [122]. 
Some authors argue that the criteria should be defined prior to treatment, by letting the 
patients quantify, e.g. on a pain scale, how great the improvement should be to be 
important [142]. However, no such alternative external anchors for self-reported question-
naires exist. A problem with the five point Likert scale for patient perceived benefit of the 
operation in paper I and II was imbalanced response alternatives: ‘‘Very much’’, ‘‘Quite a 
lot’’, ‘‘Some’’, ‘‘No’’ or ‘‘Uncertain’’. No categories for deterioration were used (Appendix A). 
In paper I we dichotomized the variable into substantial improvement (‘‘Very much’’ and 
‘‘Quite a lot’’ benefit) or not. The results from the ROC curve analyses in paper I should 
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therefore be valid, but the argument that the EQ-5D could be more capable than the ODI to 
identify patients who have deteriorated, lacks sufficient evidence. In paper III we used a 












Global perceived change scale
“How much  benefit have you had of the operation ?”
 
In large cohorts of many thousand patients, even small effects which are clinically irrelevant 
may reach statistical significance. Valid (optimal) cut-offs for success, failure and MICD are 
therefore warranted, to secure that reporting and sample size calculations are unbiased. 
 In paper IV we discussed why rates of unfavourable outcomes should include both patients 
who deteriorate (increase in ODI score) and those who have persistent severe disability (ODI 
raw score > 39) at follow-up. We stated that patients who were re-operated within the study 
period could be defined as failures. This assumption has some limitations. Most of the 
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patients who are operated for recurrent disc herniation within one year after the index 
operation have favourable final outcomes [82, 143, 144]. The distinction between failure and 
unfavourable outcomes is therefore difficult. Consequently, it would be wise to report 
unfavourable outcomes and reoperations separately.  
Those who got worse had a greater change than the MCID of 10 [93]. If disability is severe 
and for instance drops from 80 to 70 on the ODI score (12.5% improvement) after 
treatment, this would probably not be as clinically significant compared to a drop from 40 to 
30 (25% improvement). Therefore, the ODI score change can be regarded as an ordinal scale, 
making risk factor analyses based on linear regression models more difficult. This represents 
a weakness in the part of the multivariate analyses of paper IV were linearity was presumed. 
Use of logistic regression requires a categorical dependent variable. Dichotomous outcomes 
based on optimal cut-offs (paper II and III) has some advantages. The problem with skewed 
data related to the dependent variable is reduced, and risk estimates that can be expressed 
in odds ratios (OR). An OR is an easier concept to explain and discuss with the patient and 
present to the public than the regression coefficient beta (ß).  From odds (O) it is also 
possible to calculate a probability (p) (p = O/1+O), which is even more comprehendible for 
doctors and patients in clinical decision making.  The results of the binary logistic analyses in 
Paper IV could have been more enlightening if we had reported the strength of the 
association between predictor and outcome by OR and not ß, like in paper II. The main 
problem with dichotomization of continuous variables is that they do not make full use of 
information in the response scale, resulting in loss of statistical power and problems with 
evaluating dose-response effects. [145]. 
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9.3 Using registry data for risk assessment and clinical guideline 
development  
Defining and reporting risk factors for unfavourable outcomes is not straight forward. A 
potential weakness of the registry design is that psychosocial factors, which can account for 
a significant proportion of the variation in the outcome measures  [146], only are evaluated 
as part of the  EQ-5D (last item: about anxiety and/or depression). Since psychosocial factors 
might be important confounders, there is an ongoing discussion in the board of the 
NORspine if a more specific instrument should be included in the next version of the 
questionnaires. However, a recent paper showed that psychological disturbance can be the 
consequence of longstanding pain and disability, rather than a cause for patients reporting 
poor outcomes. The Psychological disturbance seems to improve when symptoms resolve 
after successful surgery [147]. 
Stepwise regression analysis uses p-value (chance) related criteria for building a statistical 
model, but the best strategy for selecting variables is to use clinical judgment. It is therefore 
crucial for confounding adjustment that only clinically relevant variables are included in the 
regression model, and that they are checked for interactions and inter-correlations. When 
our registry was designed, known factors (e.g. among baseline characteristics) that were 
judged to be clinically relevant to outcome were included with the purpose of performing 
risk factors analyses [148-159].  The predictors assessed in paper IV and II were chosen 
based on their clinical relevance to the research questions. It is therefore unlikely that we 
identified independent risk factor by chance, due to multiple testing. However, the creation 
of the regression models could have been described more thoroughly. The patient 
population was relative small (n= 180) in paper IV, and risk factors analyses were linked to a 
small proportion of them (4 %). We might therefore have failed to identify other relevant 
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risk factors (type II error).  In study II and IV we included the pre-treatment score as 
independent in the multivariate analyses. Whether this method is appropriate is still 
controversial, and discussed in the literature [160]. The relationship between the 
preoperative score and its improvement at follow-up has not only statistical relevance. 
Recent results from a much greater population included in the NORspine confirms that weak 
indications for surgery (less disability prior to surgery) is a strong predictor for deterioration 
and no or clinically insignificant improvement after surgery. Conversely, severe disability 
predicts a large amount of improvement. This applies for all outcome measures including leg 
pain (Figure 5). 
Figure 5: The impact of the intensity of preoperative leg pain (numerical rating scale) on its 
improvement after surgery (NORspine 2011, n= 8.239) 








10. Future perspectives 
To secure sufficient data quality in this new field of clinical research, validation of the 
methodology will be a continuous process. Data have to be collected before being validated, 
and methods have to be tested and revised while the registry cohort expands and goes 
forward. By signing the declaration of consent of the NORspine, the patients approve to no 
time limit for use of the data, that they can be contacted again by researchers, and that 
merging data with several other registries and cohorts can be done. This makes extensive 
research linked to the NORspine possible. (Appendix C) 
Comparing results of a strict multi-centre RCT with “real life” outcome data from routine 
practice can be possible if a RCT is performed within framework of the registry, using the 
same questionnaires. New treatments often are introduced simultaneously in both settings, 
and this approach could contribute to better understanding of both efficacy and 
effectiveness of interventions, and the external validity of the RCT can then be assessed.  
Long term outcome evaluations, e.g. after ten years, can be accomplished if advocated. 
Combining information about adverse events and patient centred outcomes can provide a at 
least a crude measure of hazards and consequences (risk score) which can be compared and 
reported over time and across the surgical units [19, 28]. Involvement of patients in 
reporting adverse events has been recommended [29, 44, 161]. Most complications become 
evident after discharge [125, 162-164], and are usually not documented in hospital records 
[29, 30, 164]. Although patients tend to report more complications than clinicians, the 
agreement seems to be moderate to strong [123, 165]. Mail responses from patients could 
in fact be less biased than those obtained in the hospital setting. A Swedish study by Öhrn et 
al. showed that surgical site infections after spine surgery was under-reported in the 
SWEspine, which prompted the SWEspine to start using patient reported complications 
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[124]. The method was adopted by the NORspine in 2009, but it needs further validation in 
future studies. Benchmark criteria for adverse outcomes have to be defined so that we can 
find modifiable risk factors for prevention.  
To secure implementation of guidelines, new knowledge needs to be fed back to health 
workers and patients in a timely, relevant, understandable manner, utilizing the new social 
media. Shared decision making between doctors and patients can be facilitated if 
understandable registry reports about risks and outcomes are communicated to the 
patients, but efficient and valid methods have yet to be developed and tested. It is also 
important to find ways to ensure that guidelines are implemented and followed by the 
clinical teams. If reduction of loss to follow-up can be achieved by contacting patients by 
SMS or via the internet, as suggested in paper II, needs to be investigated. 
 
Merging data from the NORspine and the Norwegian patient registry for health services 
research has already been accomplished.  At least between some regions, there are large 
differences in the use of lumbar spine surgery (population rates) [15, 166], and overuse of 
surgery may be a problem. Relating outcome to volume of surgery at hospitals and different 
surgical rates in populations may become important aspects of quality improvement, 
especially for repeat surgery. How social inequity affects patients’ access to treatments, 





11. Main conclusions 
 The EQ-5D is valid and reliable for assessing patients undergoing low back surgery for 
degenerative disorders, and could be used to evaluate overall treatment effects.  
Hence, this instrument would provide data for cost-utility analyses. The 
sensitivity/specificity values were too low to be used for sample size calculations and 
for defining cut-offs for success or MCID.  
 
 The ODI and the NRS leg pain scale showed the best ability to discriminate between 
success or lack of success in patients who had been operated for lumbar disc 
herniation. We recommend that a change score of at least 20 points in the ODI and 
of at least 3.5 in NRS leg pain should be achieved to ensure a successful outcome 
after surgery. These cut-offs can enhance interpretation of outcomes across different 
surgical units and monitoring effectiveness. To calculate an accurate rate of 
unfavourable outcomes, both changes in disability scores and the actual raw score at 
follow-up should be evaluated.  
  
 A loss to follow-up of 22% would not bias conclusions about overall treatment effects 
and, importantly, there were no indications of worse outcomes among non-
respondents. Younger patients and those not experiencing complications were less 
likely to respond, and forgetfulness may be an important cause. 
 
 The risk for deterioration is after lumbar microdiscectomy is small (4%), but larger if 
the patient has been unable to work despite relatively small health problems. For 
these patients, the indication for surgery could be stricter. These matters should be 
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Ia Patient questionnaire 




Ib Patient questionnaire 


















































































































































13.2.2 Appendix B 
 





Ia Patient questionnaire 
IIa Surgeon/staff questionnaire 
 
Follow-up:  
Ib (2) Patient questionnaire 
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